Skip to main content

Table 5 Differentially expressed genes

From: Distinct choline metabolic profiles are associated with differences in gene expression for basal-like and luminal-like breast cancer xenograft models

Entrez ID Probe name Gene name Encoded protein Log2-fold difference Adjusted p-value (false discovery rate)
50487 A_23_P17814 PLA2G3 Phospholipase A2, group III -3.1 1.1E-12
81579 A_23_P30020 PLA2G12A Phospholipase A2, group XII A -1.6 2.5E-9
56994 A_23_P105571 CHPT1 Choline phosphotransferase 1 -1.4 1.6E-7
23446 A_23_P216630 SLC44A1 Solute carrier family 44, member 1 (CTL1) -1.1 7.9E-7
5338 A_23_P4308 PLD2 Phospholipase D2 -1.1 1.2E-6
8399 A_23_P88767 PLA2G10 Phospholipase A2, group X -1.1 3.1E-6
1119 A_23_P314120 CHKB Choline kinase beta -0.8 2.0E-6
11313 A_24_P276490 LYPLA2 Lysophospholipase II -0.4 0.005
5130 A_23_P252681 PCYT1A Phosphate cytidylyltransferase 1, choline, alpha -0.4 0.035
24657 A_23_P84666 GDPD1 Glycerophosphodiester phosphodiesterase domain containing I -0.4 0.005
1119 A_23_P124742 CHKA Choline kinase, alpha -0.3 0.047
  1. Genes directly involved in choline metabolism with significantly lower expression in basal-like (MAS98.12) than luminal-like (MAS98.06) tumors